Conventional chemotherapy has been, for many years, the prevalent type of anti-cancer treatment. However its broad-based mechanisms, DNA alkylating agents, usually lead to severe systemic side effects.  Dr. Rajendra Kumari at Precos Ltd, looks into how today the treatments inhibiting specific molecules that have a role in tumour growth or progression have become successful.
 https://international-pharma.com/wp-content/uploads/2014/01/Improving.pdf